taking

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-‘749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed

Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with…

4 weeks ago

Novo Nordisks oral semaglutide 25 mg (Wegovy in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study

Oral semaglutide 25 mg (the once-daily pill formulation of Wegovy®) achieved significant weight loss, with one in three study participants…

4 weeks ago

TokenFi Sponsors Englands T20 Matches

Wednesday 17 September, 2025 TokenFi Partners with England tour of Ireland 2025 as Title Sponsor TokenFi branding to feature across…

4 weeks ago

World’s Largest Toy, Baby, Licensing & Preschool Expo: Connecting Integrated Sourcing Under One Roof

SHANGHAI, Sept. 16, 2025 /PRNewswire/ -- 2025 China Toy Expo (CTE), China Kids Fair (CKE), China Licensing Expo (CLE) and…

4 weeks ago

People taking Novo Nordisks Wegovy experienced reduced food noise and boosted mental well-being

Results from a real-world survey suggest that semaglutide for weight management (Wegovy®) helped suppress food noise – unwanted and intrusive…

1 month ago

GENESIS MAGMA RACING DRIVERS SHOW PACE AND DECISIVE STRATEGY TO SCORE THIRD WIN OF ELMS SEASON AT SILVERSTONE

Genesis Magma Racing Trajectory drivers Jamie Chadwick and Mathys Jaubert, along with Dani Juncadella, scored a third win of the…

1 month ago

AppFolio Ignites the Next Era of Real Estate at FUTURE 2025

SAN DIEGO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- AppFolio (NASDAQ:APPF), the technology leader powering the future of the real estate…

1 month ago

KFSHRC to Partake Tomorrow as Strategic Partner in C3 Davos of Healthcare New York Summit

NEW YORK, Sept. 07, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) will participate tomorrow (Monday)…

1 month ago

Cureus Updates Terms & Conditions to Prohibit AI Use

SAN FRANCISCO, Sept. 4, 2025 /PRNewswire/ -- In an era dominated by artificial intelligence, the Cureus Journal of Medical Science…

1 month ago

HUTCHMED Highlights Clinical Data to be Presented at the 2025 World Conference of Lung Cancer and the CSCO Annual Meeting 2025

September 04, 2025 20:00 ET  | Source: HUTCHMED (China) Limited HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Sept. 05,…

1 month ago